News & Updates
Filter by Specialty:
GLP-1 RAs vs SGLT2 inhibitors: What are the comparative risks of ischaemic stroke and incident AF?
A population-based retrospective study of Hong Kong patients with type 2 diabetes (T2D) finds that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a lower risk of ischaemic stroke, while use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is associated with a lower risk of atrial fibrillation (AF).
GLP-1 RAs vs SGLT2 inhibitors: What are the comparative risks of ischaemic stroke and incident AF?
08 Mar 2023
Whole grain intake helps prevent cardiac events, death
Whole grain consumption, instead of refined grains, provides a protective benefit against coronary heart disease (CHD), cardiovascular disease (CVD), and all-cause mortality, suggests a study.
Whole grain intake helps prevent cardiac events, death
05 Mar 2023
FDRS variables predict Alzheimer's, dementia in HF, AF patients
Variables from the Framingham Heart Study Dementia Risk Score (FDRS) are predictive of Alzheimer’s disease (AD) and AD-related dementias (ADRD) in patients with heart failure (HF) or atrial fibrillation (AF), a study has shown.
FDRS variables predict Alzheimer's, dementia in HF, AF patients
03 Mar 2023
HPV infection ups CVD risk, but not in vaccinated women
Human papillomavirus (HPV) infection appears to be a risk factor for cardiovascular diseases (CVDs), suggests a recent study. However, women vaccinated against HPV are protected against such risk.
HPV infection ups CVD risk, but not in vaccinated women
02 Mar 2023
Which factors shape decisions to withdraw life support in stroke patients?
The decision to withdraw life-sustaining therapy (WLST) among acute hospitalized stroke patients is determined by several factors, including age, race, level of consciousness, state region, insurance status, ambulation status at baseline, and stroke centre type, suggests a study presented at ISC 2023.
Which factors shape decisions to withdraw life support in stroke patients?
02 Mar 2023
Statin therapy reduces major vascular events after stroke
Treatment with statin results in a decrease in major vascular events following acute ischaemic stroke, even in patients with low or well-controlled low-density lipoprotein cholesterol (LDL-C), as shown in a study presented at ISC 2023.
